Cabozantinib for treating medullary thyroid cancer (TA516)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 March 2018
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy (TA117)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 January 2007
Etelcalcetide for treating secondary hyperparathyroidism (TA448)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 June 2017
High-intensity focused ultrasound for symptomatic benign thyroid nodules (IPG643)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 February 2019
Hyperparathyroidism (primary): diagnosis, assessment and initial management (NG132)Product type:GuidanceProgramme:NICE guidelinePublished: 23 May 2019
Intraoperative nerve monitoring during thyroid surgery (IPG255)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 March 2008
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine (TA535)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 8 August 2018
Minimally invasive video‑assisted parathyroidectomy (IPG501)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 August 2014
Minimally invasive video-assisted thyroidectomy (IPG499)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 August 2014
Mitochondrial disorders in children: Co-enzyme Q10 (ES11)Product type:AdviceProgramme:Evidence summaryPublished: 28 March 2017
Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 16 July 2025
Parathyroid autofluorescence and parathyroid angiographyStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Percutaneous Laser Ablation (PLA) for benign thyroid nodulesStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules (IPG743)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 16 November 2022
Recombinant human parathyroid hormone for treating hypoparathyroidism (terminated appraisal) (TA625)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 4 March 2020
Retrobulbar irradiation for thyroid eye disease (IPG148)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 14 December 2005
Teprotumumab for treating thyroid eye disease [ID6432]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 20 August 2025
Thyroid disease: assessment and management (NG145)Product type:GuidanceProgramme:NICE guidelineLast updated: 12 October 2023Published: 20 November 2019
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules (IPG562)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 June 2016
Vandetanib for treating medullary thyroid cancer (TA550)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 12 December 2018